Use of Ganciclovir in the Treatment of Acquired Cytomegalovirus Disease in a Preterm Infant
The first use of ganciclovir in a preterm infant is reported. The 27 week appropriate-for-gestational-age male infant developed a disseminated cytomegalovirus infection subsequent to a blood transfusion. A daily dose of 10 mg/kg administered intravenously in two divided doses for a total of 14 days...
Saved in:
Main Authors: | H Amin, T Jadavji, R Sauve, J Gill |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1990-01-01
|
Series: | Canadian Journal of Infectious Diseases |
Online Access: | http://dx.doi.org/10.1155/1990/917057 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Resolution of Mild Ganciclovir-Resistant Cytomegalovirus Disease with Reduced-Dose Cidofovir and CMV-Hyperimmune Globulin
by: Samir J. Patel, et al.
Published: (2014-01-01) -
Pulmonary Effects of Neonatal Hydrocortisone Treatment in Ventilator-Dependent Preterm Infants
by: Sandra E. A. de Jong, et al.
Published: (2011-01-01) -
The Use of N-Terminal-Pro-BNP in Preterm Infants
by: Afif EL-Khuffash, et al.
Published: (2009-01-01) -
Pharmacological Therapy of Gastroesophageal Reflux in Preterm Infants
by: Luigi Corvaglia, et al.
Published: (2013-01-01) -
Congenital Cytomegalovirus Infection Presenting with Hyperbilirubinemia and Splenomegaly in a Term Infant with Trisomy 21
by: Kate Wilson, et al.
Published: (2020-01-01)